Enzymatic inhibitors that slow down the production of ROS (reactive oxygen species) have been shown to be effective in mitigating the effects of a stroke. Additional effects, such as reduced growth of cancer cells have also been detected. This area of research is very exciting as no approved drugs with similar effects are available today.
Evaluation of new pharmaceutical compounds and their effects in the area of cancer and also in stroke
Research Group Translational Medicine TRIM
Resarch Environment DHEAR – for a healthier and more sustainable soci
Quick Facts
Full project name
The effect that Nox2 and Nox4 inhibitors have on cancer and strokeDuration
January 2016 – December 2025Funding and collaboration
Glucox Biotech ABParticipating Researchers
Ferenc Szekeres
Senior Lecturer in Biomedicine
Helene Lindholm
PhD Student Biomedicine
Per Wikström
Glucox Biotech AB